These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2501817)

  • 21. [Effects of thyrotropin-releasing hormone (TRH) on status epilepticus in rats].
    Osonoe K; Mori N; Ohno E; Kumashiro H
    No To Shinkei; 1991 Mar; 43(3):247-54. PubMed ID: 1907468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two trials of antenatal thyrotrophin-releasing hormone for fetal maturation: stopping before the due date. Antenatal TRH Trial and the Thyroneth Trial Groups.
    Alfirevic Z; Boer K; Borcklehurst P; Buimer M; Elbourne D; Kok J; Tansey S
    Br J Obstet Gynaecol; 1999 Sep; 106(9):898-906. PubMed ID: 10492099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ECT and TRH: cholinergic involvement in a cognitive deficit state.
    Khan A; Mirolo MH; Lai H; Claypoole K; Bierut L; Malik R; Bhang J
    Psychopharmacol Bull; 1993; 29(3):345-52. PubMed ID: 8121962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM; Taft JA; Reichlin S; Munsat TL
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple-dose arecoline infusions in Alzheimer's disease.
    Tariot PN; Cohen RM; Welkowitz JA; Sunderland T; Newhouse PA; Murphy DL; Weingartner H
    Arch Gen Psychiatry; 1988 Oct; 45(10):901-5. PubMed ID: 3048224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central thyrotropin-releasing hormone infusion opposes cardiovascular and metabolic suppression during caloric restriction.
    Knight WD; Swoap SJ; Parsons AD; Overton JM
    Neuroendocrinology; 2006; 83(2):69-76. PubMed ID: 16785745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies.
    Brooks BR; Sufit RL; Montgomery GK; Beaulieu DA; Erickson LM
    Neurol Clin; 1987 Feb; 5(1):143-58. PubMed ID: 3104750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.
    Callahan AM; Frye MA; Marangell LB; George MS; Ketter TA; L'Herrou T; Post RM
    Biol Psychiatry; 1997 Feb; 41(3):264-72. PubMed ID: 9024949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of amyotrophic lateral sclerosis with thyrotropin-releasing hormone (TRH).
    Yamane K; Osawa M; Kobayashi I; Maruyama S
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):179-87. PubMed ID: 3097367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australian collaborative trial of antenatal thyrotropin-releasing hormone (ACTOBAT) for prevention of neonatal respiratory disease.
    Lancet; 1995 Apr; 345(8954):877-82. PubMed ID: 7707809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intravenous thyrotropin-releasing hormone on urethral closure pressure in females with voiding dysfunction.
    Rosario DJ; Woo HH; Parkhouse H; Chapple CR
    Eur Urol; 1995; 28(1):64-7. PubMed ID: 8521898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of amyotrophic lateral sclerosis with TRH].
    Klimek A; Szulc-Kuberska J; Czernielewska-Rutkowska I; Głuszcz-Zielińska A
    Neurol Neurochir Pol; 1988; 22(3):206-10. PubMed ID: 3146705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous nicotine in Alzheimer's disease: a pilot study.
    Newhouse PA; Sunderland T; Tariot PN; Blumhardt CL; Weingartner H; Mellow A; Murphy DL
    Psychopharmacology (Berl); 1988; 95(2):171-5. PubMed ID: 3137593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiorespiratory alterations produced by centrally administered thyrotropin-releasing hormone during canine endotoxin shock.
    Leffew SD; Williams CD; Janssen HF
    Circ Shock; 1987; 21(3):225-32. PubMed ID: 3105908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.